Evonik Industries AG (EVKIY) Stock Price & Analysis
Evonik Industries AG (EVKIY) — price $10.00 (-16.39%), as of the Nov 19, 2026 trading session; market cap $9.32B.
Educational signal · not a buy or sell recommendation · How to read this
Evonik Industries AG · EVKIY · Basic Materials · Chemicals - Specialty
Evonik Industries AG is a prominent company specializing in the field of chemical production.
Price as of Nov 19, 2026
Key Statistics
No MoonshotScore yet: we have not published a score for this company.
Thousands of the 20,000+ US stocks here carry a MoonshotScore.
Scored companies in the same industry:
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $10.00 | |
| Change on the day | -16.39% | |
| 52-week range | $7.24–$12.29 | |
| Market capitalisation | $9.32B | — |
| Price / earnings (trailing) | 58.32 | |
| Shares traded on the day | 2.7K | |
| Beta (volatility vs the S&P 500) | 0.44 | |
| Dividends per share (last 12 months) | $0.58 | |
| Dividend yield (last 12 months) | 4.83% |
Price & events
Triangles mark reported quarters on the line: pointing up is above the recorded estimate, down is below, a diamond means no estimate on file or a dated event that is not a results report. Numbers key to the dated list. Point at or tab to any week for its close.
Events behind the price
- · Earnings results
- · Earnings results
- · Earnings call · management outlook
Results dates follow the earnings feed; call dates follow the transcript provider. Nearby dates do not establish that an event caused a price move.
Management outlook
In the next 3 years, we will shape Evonik into a different company, a company that is much more focused on its core, that is much more agile and that in the end, latest by 2029, will earn more than its cost of capital.
Claus Rettig · Statement from
We will post a ROCE of around 11% latest by 2029 with a continuously high cash generation.
Claus Rettig · Statement from
How to read these dates
A statement's date is the earnings call where it was made, not a deadline. Management expectations can change.
Other perspectives
Council score for Evonik Industries AG (EVKIY): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Legends Council
3 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Sep 11, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Sep 11, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Sep 11, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is Evonik Industries AG (EVKIY), and what does it report?
Short answer
Evonik Industries AG is a prominent company specializing in the field of chemical production. Basic Materials / Chemicals Specialty Headquarters: Rellinghauser Strasse 1-11, Essen, NW, 45128, DE. It employs 31,053 people and is led by Claus Rettig. In Q3 FY2026 it reported revenue of €3.80B and net income of -€53M. The market values it at $9.32B.
What do the latest results show for Evonik Industries AG (EVKIY)?
Short answer · as of
The most recent reported quarter, Q3 FY2026, carried revenue of €3.80B.
Did results meet expectations?
Reported earnings and revenue alongside the estimates recorded by the provider.
- Latest report · revenue
- $3.94B May 11, 2026
- Latest report · revenue estimate
- $4.16B May 11, 2026
- Latest report · revenue vs estimate
- Below estimate May 11, 2026
| Report date | Revenue · reported | Revenue · estimate | EPS · reported | EPS · estimate |
|---|---|---|---|---|
| May 11, 2026 | $3.94B | $4.16B | $0.1554 | Not available |
| Mar 3, 2026 | $4.00B | $3.37B | $0.0225 | Not available |
| Aug 1, 2025 | $4.12B | $3.42B | $0.1516 | Not available |
| May 12, 2025 | $4.14B | $3.86B | $0.5480 | Not available |
How to read these figures
Dates are when results were reported, not quarter ends. Amounts are in US dollars; EPS is per share. The source does not say whether EPS is basic, diluted or adjusted, so it can differ from the EPS in the income statement.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q3 FY2026 | €3.80B | -€53M | -€0.06 (diluted) |
| Q2 FY2026 | €3.89B | €84M | €0.09 (diluted) |
| Q1 FY2026 | €3.43B | €125M | €0.14 (diluted) |
| Q4 FY2025 | €3.40B | €18M | €0.02 (diluted) |
What are the financial strengths and risks for Evonik Industries AG (EVKIY)?
Short answer · as of
The distress and quality screens read Altman Z 2.07 · Piotroski F 7. Trailing ratios: ROE 2.2% · ROA 0.9% · current ratio 1.27 · earnings yield 1.8% · free-cash-flow yield 9.3%.
The records behind this page
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held EVKIY in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported EVKIY in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
What has been published about Evonik Industries AG (EVKIY)?
Common Questions About EVKIY (Basic Materials)
Research dated 2026-09-13; the full attribution is under Sources. The last 2 questions are answered from this page's own dated data, not from the research.
How does methionine fit into Evonik’s business?
Methionine and related products sit within Nutrition & Care and serve animal-nutrition demand. This links part of Evonik’s earnings to feed and livestock supply chains rather than only to conventional industrial chemical markets.
What does Evonik’s Technology & Infrastructure business provide?
It provides site management, utilities, waste handling, technical support, process development, engineering and logistics. These activities make Evonik a combination of specialty-product operations and an industrial-services platform.
What is the EVKIY stock price today?
The last price recorded for Evonik Industries AG (EVKIY), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
Does EVKIY pay a dividend?
Yes. The dividend yield of Evonik Industries AG (EVKIY) over the last 12 months, with its date, is listed under Price & valuation on this page. Payout ratio and cash-flow coverage decide whether it can last, and past dividends do not guarantee future payments.
Research written by Codex (gpt-5.6-sol) on 2026-09-13. AI-authored analysis; source dates are listed under Sources. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 34 figures on this page — 1 from SEC filings and earnings calls, 27 from Financial Modeling Prep (FMP), 3 with no recorded source and 3 computed by us, formula shown in the register. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com